Trial Profile
Effect of Milnacipran on Pain Processing and Functional Magnetic Resonance Imaging (fMRI) Activation Patterns in Patients With Fibromyalgia.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 24 May 2021
Price :
$35
*
At a glance
- Drugs Milnacipran (Primary)
- Indications Fibromyalgia
- Focus Pharmacodynamics; Registrational
- Sponsors Forest Laboratories
- 13 May 2021 Results of an exploratory study from two cross-over double-blind studies (NCT00793520 and NCT00793520) in FM patients participated: published in the Arthritis and Rheumatology
- 14 Nov 2012 Results of brain activity analyses presented at the 76th Annual Scientific Meeting of the American College of Rheumatology and the 47th Annual Meeting of the Association of Rheumatology and Health Professionals.
- 14 Nov 2012 Results of brain connectivity analyses presented at the 76th Annual Scientific Meeting of the American College of Rheumatology and the 47th Annual Meeting of the Association of Rheumatology and Health Professionals.